How good is this data from Pfizer?
$PFE.US$ $GILD.US$ $MRK.US$ $VIR.US$
Calculating the statistical error, it is similar or stronger than remdesivir alone. (It is not ruled out that Gilead will use HIV medicine to make a better one in the future)
The MSD case was scrapped. So sorry for MSD shareholders. They have had to be sued for a long time. Fortunately, value stocks can always pay for themselves in a year or two. MSD's AIDS program also deserves attention.
I lost all of my earnings from Pfizer to Grandpa VIR. I picked up VIR's flying knife, go ahead, go ahead
Calculating the statistical error, it is similar or stronger than remdesivir alone. (It is not ruled out that Gilead will use HIV medicine to make a better one in the future)
The MSD case was scrapped. So sorry for MSD shareholders. They have had to be sued for a long time. Fortunately, value stocks can always pay for themselves in a year or two. MSD's AIDS program also deserves attention.
I lost all of my earnings from Pfizer to Grandpa VIR. I picked up VIR's flying knife, go ahead, go ahead
update. Pfizer is a combination of PF-07321332 and the HIV drug ritonavir (unpatented). Note that last year's World Health Organization solidary solidarity trial concluded that lopinavir + ritonavir was not effective; it was a proper academic misconduct. Biden is strong; sure enough, he knew something in advance. I just think everyone really has to check their holdings. Stocks that have benefited from the pandemic have to take profits in a timely manner; if you don't want to step on PTON, you can't run at all.
According to the experimental data, in fact, the PFE, MRK, and WHO solidarity all played a trick, comparing chickens to ducks. Can data from Americans, Indians, and South Americans be pooled together?
In terms of valuation. A signed contract will definitely be executed as long as it is approved. If the government has a budget, who cares which one is strong? Currently, there is still a shortage of medicines, and there is a shortage of antibodies. That's why REGN VIR was fried for a short time. How much is this Pfizer worth? As a covid drug, the market is definitely overvalued. It goes up a wave and then falls. Then Pfizer will do more experiments, eat more of this fish, and make a fortune by making a broad spectrum anti-virus. So is MSD. MRNA and BNTX are good companies, but they always have to be valued, and why don't they increase sales at high prices? Gilead's side... if it didn't fall, it was a huge victory. The picture was ruined again by MSD's news... but anyway, it's cheap, hold it
According to the experimental data, in fact, the PFE, MRK, and WHO solidarity all played a trick, comparing chickens to ducks. Can data from Americans, Indians, and South Americans be pooled together?
In terms of valuation. A signed contract will definitely be executed as long as it is approved. If the government has a budget, who cares which one is strong? Currently, there is still a shortage of medicines, and there is a shortage of antibodies. That's why REGN VIR was fried for a short time. How much is this Pfizer worth? As a covid drug, the market is definitely overvalued. It goes up a wave and then falls. Then Pfizer will do more experiments, eat more of this fish, and make a fortune by making a broad spectrum anti-virus. So is MSD. MRNA and BNTX are good companies, but they always have to be valued, and why don't they increase sales at high prices? Gilead's side... if it didn't fall, it was a huge victory. The picture was ruined again by MSD's news... but anyway, it's cheap, hold it
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
CFA, FRM, P-Quant。然而自己投资并不量化…个人投资观点，不代表供职的银行或客户（反正我看不到）。不提供投资建议。
206Followers
19Following
1687Visitors
Follow